Codexis (CDXS) Change in Accured Expenses (2010 - 2020)
Codexis' (CDXS) quarterly Change in Accured Expenses came in at $3.9 million in Q4 2020, up 39.04% year-on-year from $2.8 million in Q1 2020, and up 305.85% quarter-over-quarter from -$1.9 million in Q1 2020.
Codexis (CDXS) Change in Accured Expenses (2010 - 2020) Analysis & Trends
Codexis' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $3.9 million for Q4 2020.
- On a quarterly basis, Change in Accured Expenses rose 39.04% year-over-year to $3.9 million in Q4 2020; TTM through Dec 2020 was $4.9 million, a 122.9% increase from a year earlier, with the FY2022 full-year figure at $6.0 million, down 9.0% from the prior year.
- Change in Accured Expenses climbed to $3.9 million in Q4 2020 per CDXS's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.9 million in Q4 2020 and bottomed at -$1.9 million in Q2 2019.
- The 5-year median for Change in Accured Expenses is $424500.0 (2018), against an average of $393222.2.
- Across the five-year window, Change in Accured Expenses jumped 472.64% in 2017 and sank 654.72% in 2019, its largest moves.
- Year by year, Change in Accured Expenses stood at $923000.0 in 2016, then plunged by 196.21% to -$888000.0 in 2017, then climbed by 6.53% to -$830000.0 in 2018, then jumped by 435.18% to $2.8 million in 2019, then surged by 39.04% to $3.9 million in 2020.
- Per Business Quant, the three latest CDXS Change in Accured Expenses figures stand at $3.9 million (Q4 2020), -$1.9 million (Q1 2020), and $2.8 million (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Codexis | 139.78 Mn | 74.64 Mn | 13.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 3.87 Mn |
| Dec 31, 2020 | 3.87 Mn |
| Mar 31, 2020 | -1.88 Mn |
| Mar 31, 2020 | -1.88 Mn |
| Dec 31, 2019 | 2.78 Mn |
| Dec 31, 2019 | 2.78 Mn |
| Sep 30, 2019 | 144,000.00 |
| Sep 30, 2019 | 144,000.00 |
| Jun 30, 2019 | -1.92 Mn |
| Jun 30, 2019 | -1.92 Mn |
| Mar 31, 2019 | 1.20 Mn |
| Mar 31, 2019 | 1.20 Mn |
| Dec 31, 2018 | -830,000.00 |
| Dec 31, 2018 | -830,000.00 |
| Sep 30, 2018 | 881,000.00 |
| Sep 30, 2018 | 881,000.00 |
| Jun 30, 2018 | -254,000.00 |
| Jun 30, 2018 | -254,000.00 |
| Mar 31, 2018 | 705,000.00 |
| Mar 31, 2018 | 705,000.00 |